Biomedical subjects

Michael H Young

Publications and source records attributed to Michael H Young.

3 recordsLinked to original sources

PubMed2006

Therapies for necrotising fasciitis.

Necrotising fasciitis is a rare but life-threatening infectious disease emergency. Delays in diagnosis and treatment are common, and mortality rates often exceed 30%. Successful management of this disease requires high clinical suspicion and aggressive action. The mainstays of therapy include early and wide surgical debridement, antibiotics and supportive care, with prompt surgical intervention. Adjunctive modalities, such as protein synthesis inhibitors, hyperbaric oxygen and intravenous immunoglobulin, may have a role, but their effectiveness remains unproven. New rapid diagnostic tools are emerging that promise to revolutionize early detection of necrotising fasciitis. Research into the molecular microbiology, especially regarding group A streptococcus, are providing novel insights into the pathogenesis of necrotising soft tissue infections and identifying future targets for rationally designed interventions.

Animals↗

PubMed2005

Necrotizing fasciitis: pathogenesis and treatment.

Necrotizing fasciitis is a rapidly progressive, life-threatening infection and a true infectious disease emergency. Despite much clinical experience, the management of this disease remains suboptimal, with mortality rates remaining approximately 30%. Necrotizing fasciitis rarely presents with obvious signs and symptoms and delays in diagnosis enhance mortality. Therefore, successful patient care depends on the physician's acumen and index of suspicion. Prompt surgical debridement, intravenous antibiotics, fluid and electrolyte management, and analgesia are mainstays of therapy. Adjunctive clindamycin, hyperbaric oxygen therapy and intravenous immunoglobulin are frequently employed in the treatment of necrotizing fasciitis, but their efficacy has not been rigorously established. Improved understanding of the pathogenesis of necrotizing fasciitis has revealed new targets for rationally designed therapies to improve morbidity and mortality.

Anti-Bacterial Agents↗

PubMedDate not supplied

Optimized system to improve pumping rate stability during aquifer tests.

Aquifer hydraulic properties are commonly estimated using aquifer tests, which are based on an assumption of a uniform and constant pumping rate. Substantial uncertainties in the flow rate across the borehole-formation interface can be induced by dynamic head losses, caused by rapid changes in borehole water levels early in an aquifer test. A system is presented that substantially reduces these sources of uncertainty by explicitly accounting for dynamic head losses. The system which employs commonly available components (including a datalogger, pressure transducers, a variable-speed pump motor, a flow controller, and flowmeters), is inexpensive, highly mobile, and easily set up. It optimizes the flow rate at the borehole-formation interface, making it suitable for any type of aquifer test, including constant, step, or ramped withdrawal and injection, as well as sinusoidal. The system was demonstrated for both withdrawal and injection tests in three aquifers at the Savannah River Site. No modifications to the control system were required, although a small number of characteristics of the pumping and monitoring system were added to the operating program. The pumping system provided a statistically significant, constant flow rate with time. The range in pumping variability (95% confidence interval) was from +/- 2.58 x 10(-4) L/sec to +/- 9.07 x 10(-4) L/sec, across a wide range in field and aquifer conditions.

Environmental Monitoring↗